Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Fig. 1

GFR in dependency of the number of R-DHAP courses. The diagrams show the GFR separately for patients who underwent one (a, n = 31), two (b, n = 61), three (c, n = 14) or four (d, n = 16) courses of R-DHAP, respectively. The data are presented as minimum, first quartile, median, third quartile and maximum

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us